Semi-Annual Statement Of Income And Retained Earnings

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7608023

Concept 2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
2021-04-01 to
2021-12-31
Semi-annual statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
4,677,000,000 JPY
5,173,000,000 JPY
-495,000,000 JPY
4,886,000,000 JPY
286,000,000 JPY
Non-operating income
Non-operating income
367,000,000 JPY
Non-operating expenses
Non-operating expenses
254,000,000 JPY
Ordinary profit (loss)
4,790,000,000 JPY
Extraordinary income
Extraordinary income
9,425,000,000 JPY
Extraordinary losses
Extraordinary losses
8,366,000,000 JPY
Profit (loss) before income taxes
5,849,000,000 JPY
Income taxes - current
1,048,000,000 JPY
Income taxes - deferred
717,000,000 JPY
Profit (loss)
4,082,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.